Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses
Iliès Benotmane, Gabriela Gautier, Peggy Perrin, Jérôme Olagne, Noëlle Cognard, Samira Fafi‐Kremer, Sophie Caillard
Abstract
This study examines the antibody responses to a third dose (100 μg) of the mRNA-1273 SARS-CoV-2 vaccine among kidney transplant recipients in France who had not responded to 2 doses of the vaccine.
Topics & Concepts
MedicineSerologyAntibody responseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)VirologyKidney transplant2019-20 coronavirus outbreakAntibodyKidney transplantationImmunologyTransplantationPathologyInternal medicineInfectious disease (medical specialty)OutbreakDiseaseSARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and ThrombosisCOVID-19 Clinical Research Studies